Examples of Projects

  1. Time Savings of Weekly versus Three-Times-per-Week Administration of Erythropoiesis Stimulating Agents in United States Dialysis Patients
  2. A Time and Motion Study of the Preparation and Administration of IV Melphalan
  3. Quantification of the Time and Effort Required for Peripheral Blood Stem Cell Collection – The European Perspective
  4. Health Economic Analysis of Rabbit Antithymocyte Globulin (Thymoglobulin) Versus Basiliximab in Renal Transplantation – A German Perspective
  5. Retrospective Chart Reviews to Characterize Management of Patients with Unresectable or Metastatic Melanoma in Oncology Practice in Italy, France and Germany
  6. Retrospective Chart Review of Hospitalizations during Treatment of Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia in Hospitals within the European Union
  7. A Time and Motion and Facilities Observational Evaluation of Epoetin Alfa and Darbepoetin Alfa in Free-Standing Community-Based Dialysis Centers
  8. Abdominal Surgery:  A Study of Patient Outliers and Related Causes
    1. Consisted of a case-control observational record review of patient length of stay (LOS) outliers in a defined surgical population to identify drug related causes of increased LOS.
    2. Focus:  Evidence based research for product strategy development in Pain Management
  9. A Cross-sectional, Observational Time and Motion Study of Erythropoiesis-Stimulating Agents (ESAs) Use in Private Oncology Practice for Anemia due to Concomitantly Administered Myelosuppressive Chemotherapy (CIA)
    1. Determine the mean time required to complete each of 9 identified distinct steps in the process of ESA administration for CIA, for visits with and without chemotherapy administration.
    2. Focus:  Office practice dynamics and economics in Oncology
  10. Treatment Burden and Patient Considerations of Lenalidomide and Bortezomib in Multiple Myeloma
    1. An analysis of Adverse Drug Events (ADEs) and Risk Evaluation and Mitigation Strategies (REMS) programs.
    2. Focus:  Product differentiation
  11. Time and Motion Characteristics of a REMS program: Quantification of Time & Effort of Office Personnel
    1. A prospective study to quantify the staff time and effort required to complete the Baseline Data Form and evaluate the turnaround time for approval of patients following completion of the Patient Enrollment Form.
    2. Focus:  Econometric analysis
  12. The Impact of Long-Acting versus Short-Acting Growth Factors on Staff Time Consumption & Utilization
    1. An eight hospital clinic evaluation designed to address and quantify the average time for an office/clinic visit, the various events that take place during that visit, and the average total time consumed by staff and patients engaged in providing growth factor injections.
    2. Focus: Economics of anemia management
  13. Administration of Therapeutic Monoclonal Antibodies in Oncology
    1. Evaluate the impact of Adverse Drug Events (ADEs) and infusion reactions on patients and staff.
    2. Focus:  Product positioning analysis
  14. Time and Resource Utilization in Blood Transfusion: Impact of Blood Transfusion for Oncology Clinics and Blood Banks
    1. Measure of the time consumed by PRBC transfusion and the costs associated with routine PRBC transfusion and identify adverse transfusion events, their incidence, and estimate associated treatment costs.
    2. Focus:  Econometric analysis
  15. Office practice dynamics – a study of a potential new agent for osteoporosis
    1. A 12-practice analysis designed to provide an in-depth knowledge of primary care practices and what issues are key in the decision making process and daily functioning of the practice.
    2. Focus:  Market research
  16. Current Trends and Needs in the Management of the High-Risk Prostate Cancer Patient
    1. Evaluated the econometric dynamics within a private urology practice where most of the control and decision making for patient care occurs including internal and external environmental factors.
    2. Focus:  Analytical product positioning analysis
  17. Comparative Safety of Filgrastim versus Sargramostim in Patients Receiving Myelosuppressive Chemotherapy
    1. A 10-practice evaluation/analysis of the incidence and impact of adverse events on clinical outcomes.
    2. Focus:  Product differentiation
  18. The Impact of a Long-Acting Growth Factor on Practice Dynamics in a University Hospital Outpatient Clinic
    1. A study to identify usage patterns and utilization of the growth factors in the institutional ambulatory care setting combined with results of the time/motion study to determine growth factor time utilized per cycle.
    2. Focus:  Evidence-based utilization and econometric analysis
  19. Profiling the Institutional Provider in the evolving U.S. Healthcare Market
    1. Provide a detailed and accurate segmentation analysis and profile of the healthcare institutions and executives who manage them.
    2. Focus:  Strategic market analysis
Copyright © 2017 RJM Group, LLC. All rights reserved. | Use & Privacy | Site Map | Admin